1-(2-萘基)-3-苯基丙烯酮 | 53744-34-6

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 直链 1,3-二芳基丙烷
• 中文名称: 1-(2-萘基)-3-苯基丙烯酮
• 中文别名: 反式-1-(2-萘基)-3-苯基-2-丙烯-1-酮
• 英文名称: (E)-1-(naphthalen-2-yl)-3-phenylprop-2-en-1-one
• 英文别名: 1-(2-Naphthyl)-3-phenylprop-2-en-1-one；(E)-1-naphthalen-2-yl-3-phenylprop-2-en-1-one
• CAS: 53744-34-6
• 化学式: C₁₉H₁₄O
• 分子量: 258.32
• InChiKey: DAJQCRGTLOLIJQ-JLHYYAGUSA-N

物化性质

• 熔点：
  105 °C(Solv: ethyl ether (60-29-7))
• 沸点：
  441.1±28.0 °C(Predicted)
• 密度：
  1.153±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.3
• 重原子数：
  20
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  17.1
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  1-(2-萘基)-3-苯基丙烯酮 在 magnesium oxide 、 sodium hydroxide 作用下， 以 乙醇 、 水 、 甲苯 为溶剂， 反应 6.0h， 生成 2-[3-(2-naphthalenyl)-3-oxo-1-phenylpropyl]malonic acid
  参考文献：
  名称：

  2-(3-Oxo-1,3-diphenylpropyl)malonic Acids as Potent Allosteric Ligands of the PIF Pocket of Phosphoinositide-Dependent Kinase-1: Development and Prodrug Concept

  摘要：

  The protein kinase C-related kinase 2 (PRK2)interacting fragment (PIF) pocket of phosphoinositide-dependent kinase-1 (PDK1) was proposed as a novel target site for allosteric modulators. In the present work, We describe the design, synthesis, and structure-activity relationship of a series of 2-(3-oxo-1,3- diphenylprapyl)malonic acids as potent allosteric activators binding, to the PIF pocket: Some congeners displayed AC(50) values for PDK1 activation in the submicromolar range. The potency of the best compounds to stabilize PDK1 in a thermal stability shift assay was in the same order Of magnitude as that of the PIF pocket binding peptide PIFtide, suggesting comparable binding affinities to the pm pocket, The crystal structure of PDK1 in complex with compound 4h revealed that additional ionic interactions are mainly responsible for the increased potency compared to the monocarboxylate analogues. Notably, several compounds displayed high selectivity for PDK1 Employing a prodrug strategy, we were able to corrroborate the novel mechanism of action in cells.

  DOI：

  10.1021/jm3010477
• 作为产物：
  描述：

  1-(萘-2-基)-3-苯基丙烷-1-酮 在 碘 、 二甲基亚砜 、 potassium iodide 作用下， 反应 16.0h， 以80%的产率得到1-(2-萘基)-3-苯基丙烯酮
  参考文献：
  名称：

  碘催化酮和醛的α，β-脱氢生成共轭烯酮和烯醛

  摘要：

  研究了酮和醛的无过渡金属α，β-脱氢反应。该反应在容易的I 2 / KI / DMSO系统中进行，以高至高收率生产相应的不饱和化合物。克级实验还表明了这种新反应在有机合成中的潜在合成价值。在反应中，DMSO既充当溶剂又充当弱氧化剂。

  DOI：

  10.1039/d0nj01244k

文献信息

• Iron-Facilitated Oxidative Radical Decarboxylative Cross-Coupling between α-Oxocarboxylic Acids and Acrylic Acids: An Approach to α,β-Unsaturated Carbonyls
  作者：Qing Jiang、Jing Jia、Bin Xu、An Zhao、Can-Cheng Guo

  DOI：10.1021/acs.joc.5b00267

  日期：2015.4.3

  The first Fe-facilitated decarboxylative cross-coupling reaction between α-oxocarboxylic acids and acrylic acids in aqueous solution has been developed. This transformation is characterized by its wide substrate scope and good functional group compatibility utilizing inexpensive and easily accessible reagents, thus providing an efficient and expeditious approach to an important class of α,β-unsaturated

  已经开发出水溶液中α-氧代羧酸与丙烯酸之间的第一个铁促进的脱羧交叉偶联反应。该转化的特征在于其底物范围宽和使用廉价且易于获得的试剂的良好官能团相容性，从而为生物活性化合物中常见的重要一类α，β-不饱和羰基化合物提供了一种有效而快捷的方法。在随后的官能化反应中也证明了偶联产物的合成潜力。初步的机理研究表明，该过程涉及自由基途径：
• [EN] ALLOSTERIC PROTEIN KINASE MODULATORS<br/>[FR] MODULATEURS DE PROTÉINE KINASE ALLOSTÉRIQUE
  申请人：UNIV SAARLAND

  公开号：WO2010043711A1

  公开（公告）日：2010-04-22

  The invention provides specific small molecule compounds that allosterically regulate the activity or modulate protein-protein interactions of AGC protein kinases and the Aurora family of protein kinases, methods for their production, pharmaceutical compositions comprising same, and their use for preparing medicaments for the treatment and prevention of diseases related to abnormal activities of AGC protein kinases or of protein kinases of the Aurora family.

  该发明提供特定的小分子化合物，这些化合物能够变构调节AGC蛋白激酶的活性或调节Aurora家族蛋白激酶的蛋白-蛋白相互作用，提供这些化合物的制备方法，包含这些化合物的药物组合物，以及它们用于制备治疗和预防与AGC蛋白激酶或Aurora家族蛋白激酶异常活动相关疾病的药物的应用。
• ALLOSTERIC PROTEIN KINASE MODULATORS
  申请人：Engel Matthias

  公开号：US20120046307A1

  公开（公告）日：2012-02-23

  The invention provides specific small molecule compounds that allosterically regulate the activity or modulate protein-protein interactions of AGC protein kinases and the Aurora family of protein kinases, methods for their production, pharmaceutical compositions comprising same, and their use for preparing medicaments for the treatment and prevention of diseases related to abnormal activities of AGC protein kinases or of protein kinases of the Aurora family.

  本发明提供了特定的小分子化合物，它们通过变构调节AGC蛋白激酶的活性或调节Aurora家族蛋白激酶的蛋白质-蛋白质相互作用，其生产方法，包含该化合物的药物组合物，以及它们用于制备治疗和预防与AGC蛋白激酶或Aurora家族蛋白激酶异常活动相关疾病的药物的应用。
• PROTEIN CROSSLINKING INHIBITOR AND USE OF THE SAME
  申请人：Mikoshiba Katsuhiko

  公开号：US20120277423A1

  公开（公告）日：2012-11-01

  The present invention relates to: a ketone compound having transglutaminase-inhibiting activity, which is represented by the following Formula 1, 2, or 3: wherein R 1 is a substituted or unsubstituted aryl or heterocyclyl group, R 2 , R 3 , and R 4 are hydrogen atoms, n is 2, X is halogen, R 5 and R 6 independently represent a hydrogen atom or a substituted or unsubstituted C1-C10 alkyl, aryl, or aralkyl group, wherein R 5 and R 6 are not hydrogen atoms at the same time, or R 5 and R 6 may be taken together to form a saturated or unsaturated and substituted or unsubstituted heterocyclyl group containing a nitrogen atom (N); an inhibitor of protein crosslinking comprising the compound; and a composition for preventing or treating a protein-crosslinking causative disease, which comprises the compound or the protein crosslinking inhibitor.

  本发明涉及：一种具有转谷氨酰胺酶抑制活性的酮化合物，由下式1、2或3表示： 其中R1是取代或未取代的芳基或杂环基团，R2、R3和R4是氢原子，n是2，X是卤素，R5和R6独立地表示氢原子或取代或未取代的C1-C10烷基、芳基或芳烷基团，其中R5和R6不同时为氢原子，或者R5和R6可以共同形成含氮原子（N）的饱和或未饱和的、取代或未取代的杂环基团；包含该化合物的蛋白质交联抑制剂；以及包含该化合物或蛋白质交联抑制剂的用于预防或治疗由蛋白质交联引起的疾病的组合物。
• Synthesis of xylal‐ and arabinal‐based crown ethers and their application as asymmetric phase transfer catalysts
  作者：Tamás Nemcsok、Zsolt Rapi、Péter Bagi、György Keglevich、Péter Bakó

  DOI：10.1002/chir.23149

  日期：2020.1

  from l‐ and d‐xylose, and l‐ and d‐arabinose, respectively. These monosaccharide‐based chiral macrocycles were tested as phase transfer catalysts in a few asymmetric reactions. The xylal‐based crown compounds proved to be efficient catalysts in a few liquid‐liquid phase reactions. The epoxidation of trans‐chalcone and the Darzens condensation of α‐chloroacetophenone with benzaldehyde took place with

  基于arabinal新xylal-和单氮杂-15-冠醚5合成从开始升-和ð木糖，和升和- d分别-arabinose。这些基于单糖的手性大环化合物在一些不对称反应中作为相转移催化剂进行了测试。在一些液相-液相反应中，基于木糖的冠状化合物被证明是有效的催化剂。反式的环氧化α-氯苯乙酮与苯甲醛的查尔酮和达岑（Darzens）缩合反应具有完全非对映选择性，分别高达ee的77％和ee的58％。发现查尔酮和α-氯乙酰苯的芳香环中的取代基对对映选择性有影响。最高的ee值来自4-氯查尔酮的环氧化（81％ee）和2-萘基类似物的反应（96％ee），而4-苯基-α-氯乙酰苯与苯甲醛的Darzens缩合反应，检测到的最大ee为91％。冠环中单糖单元的构型影响合成的环氧酮的绝对构型。